 Sarah Tevis
Concepts (231)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Breast Neoplasms | 26 | 2023 | 1846 | 7.460 |
Why?
| | Postoperative Complications | 20 | 2023 | 2122 | 2.770 |
Why?
| | Internship and Residency | 7 | 2022 | 920 | 2.190 |
Why?
| | Mammaplasty | 3 | 2022 | 68 | 2.030 |
Why?
| | Mastectomy, Segmental | 7 | 2022 | 76 | 1.980 |
Why?
| | Surgical Procedures, Operative | 8 | 2015 | 206 | 1.950 |
Why?
| | General Surgery | 5 | 2021 | 125 | 1.870 |
Why?
| | Drug Prescriptions | 3 | 2021 | 237 | 1.860 |
Why?
| | Mastectomy | 11 | 2023 | 99 | 1.720 |
Why?
| | Patient Readmission | 12 | 2019 | 607 | 1.700 |
Why?
| | Pain, Postoperative | 5 | 2022 | 190 | 1.650 |
Why?
| | Patient Reported Outcome Measures | 5 | 2023 | 251 | 1.620 |
Why?
| | Analgesics, Opioid | 5 | 2022 | 771 | 1.570 |
Why?
| | Breast Implants | 2 | 2022 | 13 | 1.430 |
Why?
| | Prophylactic Mastectomy | 2 | 2021 | 5 | 1.410 |
Why?
| | Ovarian Neoplasms | 2 | 2023 | 386 | 1.230 |
Why?
| | Communication | 3 | 2023 | 734 | 1.220 |
Why?
| | Colectomy | 4 | 2016 | 86 | 1.210 |
Why?
| | Patient Safety | 4 | 2021 | 273 | 1.180 |
Why?
| | Education, Medical, Graduate | 3 | 2021 | 366 | 1.130 |
Why?
| | Humans | 77 | 2023 | 114045 | 1.120 |
Why?
| | Quality Improvement | 10 | 2021 | 944 | 1.080 |
Why?
| | Female | 52 | 2023 | 59324 | 1.070 |
Why?
| | Ovariectomy | 3 | 2023 | 116 | 1.050 |
Why?
| | Breast | 3 | 2023 | 138 | 1.020 |
Why?
| | Surveys and Questionnaires | 14 | 2023 | 4595 | 1.020 |
Why?
| | Surgeons | 4 | 2023 | 236 | 1.000 |
Why?
| | Patients | 2 | 2023 | 163 | 0.980 |
Why?
| | Nomograms | 2 | 2015 | 41 | 0.970 |
Why?
| | Patient Satisfaction | 4 | 2021 | 571 | 0.970 |
Why?
| | Physicians | 2 | 2023 | 765 | 0.900 |
Why?
| | Lymphoma, Large-Cell, Anaplastic | 2 | 2022 | 16 | 0.850 |
Why?
| | Medical Errors | 2 | 2021 | 86 | 0.840 |
Why?
| | Hysterectomy | 2 | 2023 | 105 | 0.820 |
Why?
| | Quality of Health Care | 3 | 2018 | 572 | 0.810 |
Why?
| | Literacy | 1 | 2022 | 9 | 0.800 |
Why?
| | Delayed Diagnosis | 2 | 2020 | 71 | 0.770 |
Why?
| | Paternalism | 1 | 2021 | 4 | 0.750 |
Why?
| | Surgical Wound Infection | 2 | 2022 | 246 | 0.740 |
Why?
| | Adult | 25 | 2023 | 30375 | 0.730 |
Why?
| | Chemoprevention | 1 | 2021 | 87 | 0.720 |
Why?
| | Access to Information | 1 | 2021 | 46 | 0.720 |
Why?
| | Oxycodone | 1 | 2021 | 44 | 0.710 |
Why?
| | Practice Patterns, Physicians' | 4 | 2022 | 1175 | 0.710 |
Why?
| | Comprehension | 1 | 2022 | 151 | 0.710 |
Why?
| | Personnel Selection | 1 | 2021 | 62 | 0.700 |
Why?
| | Patient-Centered Care | 3 | 2022 | 470 | 0.700 |
Why?
| | Specialties, Surgical | 1 | 2021 | 67 | 0.700 |
Why?
| | Carcinoma, Lobular | 1 | 2020 | 44 | 0.680 |
Why?
| | Faculty | 1 | 2021 | 126 | 0.680 |
Why?
| | Quality of Life | 6 | 2022 | 2343 | 0.680 |
Why?
| | Health Literacy | 1 | 2022 | 160 | 0.680 |
Why?
| | Risk Management | 1 | 2020 | 89 | 0.670 |
Why?
| | Preoperative Care | 1 | 2022 | 319 | 0.670 |
Why?
| | Breast Implantation | 1 | 2019 | 6 | 0.670 |
Why?
| | Retrospective Studies | 20 | 2022 | 12521 | 0.670 |
Why?
| | Radiology | 1 | 2021 | 137 | 0.660 |
Why?
| | Length of Stay | 9 | 2019 | 957 | 0.660 |
Why?
| | Aged | 22 | 2022 | 18969 | 0.650 |
Why?
| | Education, Medical, Undergraduate | 1 | 2021 | 160 | 0.640 |
Why?
| | Interviews as Topic | 1 | 2021 | 575 | 0.630 |
Why?
| | Ileus | 2 | 2015 | 10 | 0.630 |
Why?
| | Sentinel Lymph Node | 1 | 2018 | 37 | 0.610 |
Why?
| | Fellowships and Scholarships | 1 | 2021 | 224 | 0.610 |
Why?
| | Intraoperative Care | 1 | 2018 | 33 | 0.610 |
Why?
| | Financing, Personal | 1 | 2018 | 24 | 0.610 |
Why?
| | Carcinoma, Ductal, Breast | 1 | 2018 | 76 | 0.600 |
Why?
| | HLA Antigens | 1 | 2019 | 220 | 0.600 |
Why?
| | Neoplasm, Residual | 1 | 2018 | 104 | 0.580 |
Why?
| | Students, Medical | 1 | 2021 | 262 | 0.570 |
Why?
| | Pain Management | 1 | 2020 | 285 | 0.570 |
Why?
| | Research Design | 1 | 2022 | 919 | 0.550 |
Why?
| | Middle Aged | 21 | 2022 | 26605 | 0.550 |
Why?
| | Lymph Node Excision | 3 | 2023 | 140 | 0.540 |
Why?
| | Prospective Studies | 8 | 2022 | 6195 | 0.530 |
Why?
| | Anastomotic Leak | 1 | 2016 | 27 | 0.530 |
Why?
| | Genetic Testing | 1 | 2018 | 381 | 0.520 |
Why?
| | Prognosis | 8 | 2023 | 3315 | 0.520 |
Why?
| | Mammography | 3 | 2021 | 101 | 0.500 |
Why?
| | Opioid-Related Disorders | 1 | 2022 | 413 | 0.500 |
Why?
| | Prophylactic Surgical Procedures | 1 | 2015 | 6 | 0.490 |
Why?
| | Burnout, Professional | 1 | 2020 | 323 | 0.480 |
Why?
| | Neoplasm Recurrence, Local | 2 | 2020 | 850 | 0.470 |
Why?
| | Electronic Health Records | 1 | 2021 | 799 | 0.460 |
Why?
| | Image Processing, Computer-Assisted | 1 | 2018 | 684 | 0.450 |
Why?
| | Sentinel Lymph Node Biopsy | 5 | 2023 | 99 | 0.450 |
Why?
| | Hospitals, Teaching | 1 | 2014 | 102 | 0.450 |
Why?
| | Health Care Surveys | 2 | 2015 | 541 | 0.440 |
Why?
| | Biomarkers, Tumor | 2 | 2020 | 1032 | 0.440 |
Why?
| | Salpingo-oophorectomy | 2 | 2023 | 11 | 0.430 |
Why?
| | Carcinoma | 1 | 2015 | 198 | 0.430 |
Why?
| | Stress, Psychological | 1 | 2020 | 944 | 0.410 |
Why?
| | Rectal Neoplasms | 1 | 2013 | 122 | 0.410 |
Why?
| | Clinical Competence | 2 | 2021 | 882 | 0.410 |
Why?
| | Surgical Oncology | 2 | 2022 | 18 | 0.410 |
Why?
| | Time-to-Treatment | 1 | 2013 | 146 | 0.400 |
Why?
| | Risk Factors | 15 | 2017 | 8614 | 0.400 |
Why?
| | Neoplasms | 2 | 2022 | 2086 | 0.400 |
Why?
| | Thyroid Neoplasms | 1 | 2015 | 271 | 0.380 |
Why?
| | United States | 11 | 2022 | 12137 | 0.380 |
Why?
| | Follow-Up Studies | 6 | 2022 | 4392 | 0.380 |
Why?
| | Gastroplasty | 1 | 2011 | 26 | 0.370 |
Why?
| | Male | 24 | 2022 | 55396 | 0.370 |
Why?
| | Neoadjuvant Therapy | 2 | 2023 | 305 | 0.350 |
Why?
| | Educational Status | 2 | 2022 | 408 | 0.340 |
Why?
| | Databases, Factual | 5 | 2019 | 1125 | 0.340 |
Why?
| | Gastric Bypass | 1 | 2011 | 91 | 0.340 |
Why?
| | Wisconsin | 5 | 2016 | 91 | 0.330 |
Why?
| | Income | 2 | 2022 | 167 | 0.320 |
Why?
| | Reoperation | 3 | 2019 | 513 | 0.320 |
Why?
| | Incidence | 5 | 2015 | 2314 | 0.320 |
Why?
| | Pandemics | 3 | 2021 | 1310 | 0.320 |
Why?
| | Obesity, Morbid | 1 | 2011 | 197 | 0.300 |
Why?
| | Comorbidity | 3 | 2019 | 1447 | 0.300 |
Why?
| | Chemotherapy, Adjuvant | 2 | 2023 | 332 | 0.300 |
Why?
| | Physician-Patient Relations | 2 | 2021 | 459 | 0.250 |
Why?
| | Lymphatic Metastasis | 3 | 2023 | 275 | 0.240 |
Why?
| | Aged, 80 and over | 7 | 2018 | 6306 | 0.240 |
Why?
| | Operating Rooms | 2 | 2023 | 85 | 0.220 |
Why?
| | Rosa | 1 | 2023 | 1 | 0.220 |
Why?
| | Hospital Mortality | 3 | 2016 | 773 | 0.220 |
Why?
| | Information Seeking Behavior | 1 | 2023 | 35 | 0.210 |
Why?
| | Antineoplastic Agents | 1 | 2013 | 1875 | 0.210 |
Why?
| | Delivery of Health Care | 2 | 2022 | 828 | 0.200 |
Why?
| | Logistic Models | 3 | 2015 | 1829 | 0.190 |
Why?
| | Body Image | 1 | 2022 | 68 | 0.190 |
Why?
| | Patient Discharge | 2 | 2020 | 770 | 0.190 |
Why?
| | Bone Marrow | 2 | 2020 | 243 | 0.190 |
Why?
| | Electronics | 1 | 2021 | 66 | 0.190 |
Why?
| | Receptor, ErbB-2 | 1 | 2023 | 300 | 0.180 |
Why?
| | Time Factors | 4 | 2022 | 6077 | 0.180 |
Why?
| | Habits | 1 | 2020 | 36 | 0.180 |
Why?
| | Checklist | 1 | 2021 | 84 | 0.180 |
Why?
| | Schools, Medical | 1 | 2021 | 121 | 0.170 |
Why?
| | Adaptation, Psychological | 2 | 2023 | 545 | 0.170 |
Why?
| | Analgesia | 1 | 2021 | 82 | 0.170 |
Why?
| | Interdisciplinary Communication | 1 | 2021 | 183 | 0.170 |
Why?
| | Neoplastic Cells, Circulating | 1 | 2020 | 57 | 0.170 |
Why?
| | Mentors | 1 | 2021 | 155 | 0.170 |
Why?
| | Nipples | 1 | 2019 | 6 | 0.170 |
Why?
| | Genotyping Techniques | 1 | 2019 | 69 | 0.160 |
Why?
| | Organ Sparing Treatments | 1 | 2019 | 31 | 0.160 |
Why?
| | Health Education | 1 | 2022 | 317 | 0.160 |
Why?
| | Program Evaluation | 2 | 2021 | 820 | 0.160 |
Why?
| | Program Development | 1 | 2021 | 339 | 0.160 |
Why?
| | Neoplasm Invasiveness | 1 | 2020 | 438 | 0.160 |
Why?
| | Referral and Consultation | 2 | 2021 | 632 | 0.160 |
Why?
| | Pilot Projects | 1 | 2023 | 1360 | 0.160 |
Why?
| | Patient Care Team | 2 | 2021 | 517 | 0.160 |
Why?
| | Qualitative Research | 1 | 2023 | 919 | 0.160 |
Why?
| | Career Choice | 1 | 2020 | 178 | 0.160 |
Why?
| | Hospitals, University | 2 | 2016 | 169 | 0.150 |
Why?
| | Breast Diseases | 1 | 2018 | 20 | 0.150 |
Why?
| | Sexual Behavior | 1 | 2022 | 434 | 0.150 |
Why?
| | Guideline Adherence | 1 | 2022 | 489 | 0.150 |
Why?
| | Surface Properties | 1 | 2019 | 385 | 0.150 |
Why?
| | Biopsy | 1 | 2022 | 1024 | 0.150 |
Why?
| | Postoperative Period | 2 | 2021 | 288 | 0.150 |
Why?
| | Gene Frequency | 1 | 2019 | 476 | 0.150 |
Why?
| | Salaries and Fringe Benefits | 1 | 2018 | 51 | 0.150 |
Why?
| | Confidentiality | 1 | 2018 | 67 | 0.150 |
Why?
| | Photography | 1 | 2018 | 88 | 0.150 |
Why?
| | Risk Assessment | 2 | 2018 | 2958 | 0.150 |
Why?
| | Informed Consent | 1 | 2018 | 158 | 0.140 |
Why?
| | RNA, Viral | 1 | 2020 | 565 | 0.140 |
Why?
| | Alleles | 1 | 2019 | 789 | 0.140 |
Why?
| | Markov Chains | 1 | 2017 | 114 | 0.130 |
Why?
| | Palliative Care | 1 | 2022 | 641 | 0.130 |
Why?
| | Multivariate Analysis | 3 | 2015 | 1422 | 0.130 |
Why?
| | Treatment Outcome | 3 | 2014 | 9049 | 0.120 |
Why?
| | Curriculum | 1 | 2021 | 813 | 0.120 |
Why?
| | Antineoplastic Combined Chemotherapy Protocols | 1 | 2023 | 1356 | 0.120 |
Why?
| | Medicare | 1 | 2020 | 661 | 0.120 |
Why?
| | Proctocolectomy, Restorative | 1 | 2015 | 19 | 0.120 |
Why?
| | Bayes Theorem | 1 | 2016 | 327 | 0.120 |
Why?
| | Rectum | 1 | 2015 | 151 | 0.110 |
Why?
| | Urinary Tract Infections | 1 | 2015 | 131 | 0.110 |
Why?
| | Colitis, Ulcerative | 1 | 2015 | 104 | 0.110 |
Why?
| | Emergencies | 1 | 2014 | 143 | 0.110 |
Why?
| | Age Factors | 1 | 2020 | 2885 | 0.110 |
Why?
| | Digestive System Surgical Procedures | 1 | 2013 | 91 | 0.100 |
Why?
| | Postoperative Care | 1 | 2014 | 223 | 0.100 |
Why?
| | Regression Analysis | 1 | 2015 | 945 | 0.100 |
Why?
| | Global Health | 1 | 2015 | 284 | 0.100 |
Why?
| | Case-Control Studies | 1 | 2019 | 3003 | 0.100 |
Why?
| | Gene Expression Profiling | 1 | 2018 | 1518 | 0.100 |
Why?
| | Axilla | 2 | 2023 | 39 | 0.100 |
Why?
| | Disease-Free Survival | 1 | 2013 | 618 | 0.100 |
Why?
| | Kaplan-Meier Estimate | 1 | 2013 | 813 | 0.090 |
Why?
| | Genetic Predisposition to Disease | 1 | 2019 | 2090 | 0.090 |
Why?
| | Adolescent | 4 | 2016 | 17800 | 0.090 |
Why?
| | Combined Modality Therapy | 1 | 2013 | 1117 | 0.090 |
Why?
| | Proportional Hazards Models | 1 | 2013 | 1078 | 0.090 |
Why?
| | Magnetic Resonance Imaging | 1 | 2021 | 3039 | 0.090 |
Why?
| | Treatment Failure | 1 | 2011 | 330 | 0.090 |
Why?
| | Disease Progression | 1 | 2017 | 2371 | 0.090 |
Why?
| | Models, Biological | 1 | 2017 | 1611 | 0.080 |
Why?
| | Cohort Studies | 1 | 2019 | 4883 | 0.080 |
Why?
| | Lymph Nodes | 2 | 2023 | 415 | 0.080 |
Why?
| | Mutation | 1 | 2019 | 3338 | 0.080 |
Why?
| | Colorectal Neoplasms | 1 | 2015 | 592 | 0.080 |
Why?
| | Young Adult | 4 | 2019 | 10444 | 0.080 |
Why?
| | Laparoscopy | 1 | 2011 | 395 | 0.070 |
Why?
| | Weight Loss | 1 | 2011 | 642 | 0.070 |
Why?
| | Mastectomy, Modified Radical | 1 | 2022 | 6 | 0.050 |
Why?
| | Intraoperative Period | 1 | 2021 | 51 | 0.050 |
Why?
| | Medical Oncology | 1 | 2022 | 229 | 0.040 |
Why?
| | Organizational Culture | 1 | 2021 | 119 | 0.040 |
Why?
| | BRCA2 Protein | 1 | 2019 | 41 | 0.040 |
Why?
| | BRCA1 Protein | 1 | 2019 | 56 | 0.040 |
Why?
| | Pain Measurement | 1 | 2021 | 441 | 0.040 |
Why?
| | Medical Records | 1 | 2018 | 153 | 0.040 |
Why?
| | Sex Factors | 1 | 2021 | 1706 | 0.030 |
Why?
| | ROC Curve | 1 | 2017 | 441 | 0.030 |
Why?
| | Health Facility Size | 1 | 2014 | 12 | 0.030 |
Why?
| | Hospitals, High-Volume | 1 | 2014 | 38 | 0.030 |
Why?
| | Preoperative Period | 1 | 2014 | 102 | 0.030 |
Why?
| | Social Work | 1 | 2014 | 74 | 0.030 |
Why?
| | Confidence Intervals | 1 | 2014 | 302 | 0.030 |
Why?
| | Quality Indicators, Health Care | 1 | 2015 | 285 | 0.030 |
Why?
| | Cost-Benefit Analysis | 1 | 2015 | 544 | 0.030 |
Why?
| | Cross-Sectional Studies | 1 | 2022 | 4402 | 0.030 |
Why?
| | Health Care Costs | 1 | 2015 | 381 | 0.020 |
Why?
| | Health Status | 1 | 2016 | 716 | 0.020 |
Why?
| | Evidence-Based Medicine | 1 | 2015 | 662 | 0.020 |
Why?
| | Odds Ratio | 1 | 2014 | 951 | 0.020 |
Why?
| | Population Surveillance | 1 | 2013 | 385 | 0.020 |
Why?
| | Prevalence | 1 | 2016 | 2247 | 0.020 |
Why?
| | Cognition Disorders | 1 | 2014 | 476 | 0.020 |
Why?
| | Chronic Disease | 1 | 2014 | 1577 | 0.020 |
Why?
| | Obesity | 1 | 2015 | 2505 | 0.010 |
Why?
|
|
Tevis's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|